United Therapeutics Corporation shares owned by Pacer Advisors
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Pacer Advisors
from 13F filings
Historical chart of Pacer Advisors investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Pacer Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $142M | 339k | 419.21 |
| 2025-06-30 | $147M | 510k | 287.35 |
| 2025-03-31 | $169M | 548k | 308.27 |
| 2024-12-31 | $211M | 598k | 352.84 |
| 2024-09-30 | $203M | 567k | 358.35 |
| 2024-03-31 | $108M | 470k | 229.72 |
| 2023-12-31 | $69M | 313k | 219.89 |
| 2023-09-30 | $55M | 245k | 225.87 |
| 2023-06-30 | $47M | 213k | 220.75 |
| 2023-03-31 | $39M | 172k | 223.96 |
| 2022-12-31 | $2.9M | 10k | 278.09 |
| 2022-09-30 | $18M | 84k | 209.38 |
| 2022-06-30 | $24M | 102k | 235.64 |
| 2022-03-31 | $9.5M | 53k | 179.40 |
| 2021-12-31 | $1.0M | 4.6k | 215.98 |
| 2021-09-30 | $3.3M | 18k | 184.60 |
| 2021-06-30 | $3.0M | 17k | 179.41 |
| 2021-03-31 | $2.2M | 13k | 167.25 |
| 2020-12-31 | $2.1M | 14k | 151.81 |
| 2020-09-30 | $2.1M | 21k | 100.99 |
| 2020-06-30 | $1.0M | 8.4k | 121.01 |
| 2019-12-31 | $1.3M | 15k | 88.10 |
| 2019-09-30 | $1.3M | 16k | 79.76 |
| 2018-12-31 | $548k | 5.0k | 108.86 |
| 2018-09-30 | $2.8M | 22k | 127.89 |
| 2018-06-30 | $1.7M | 15k | 113.16 |
| 2018-03-31 | $1.4M | 13k | 112.35 |
| 2017-12-31 | $1.8M | 12k | 147.91 |
| 2017-09-30 | $842k | 7.2k | 117.14 |
| 2017-06-30 | $873k | 6.7k | 129.78 |
| 2017-03-31 | $772k | 5.7k | 135.41 |
| 2016-12-31 | $635k | 4.4k | 143.53 |
| 2016-09-30 | $506k | 4.3k | 118.20 |
| 2016-06-30 | $422k | 4.0k | 105.83 |
| 2016-03-31 | $76k | 678 | 112.09 |
| 2015-12-31 | $103k | 657 | 156.77 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation